AAAAAA
Results: 1-25/64
Authors:
Hirose, Y
Aldape, K
Takahashi, M
Berger, MS
Feuerstein, BG
Citation: Y. Hirose et al., Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors, J MOL DIAGN, 3(2), 2001, pp. 62-67
Authors:
Green, AJ
Bollen, AW
Berger, MS
Oksenberg, JR
Hauser, SL
Citation: Aj. Green et al., Multiple sclerosis and oligodendroglioma, MULT SCLER, 7(4), 2001, pp. 269-273
Authors:
Bobola, MS
Berger, MS
Ellenbogen, RG
Roberts, TS
Geyer, JR
Silber, JR
Citation: Ms. Bobola et al., O-6-methylguanine-DNA methyltransferase in pediatric primary brain tumors:Relation to patient and tumor characteristics, CLIN CANC R, 7(3), 2001, pp. 613-619
Authors:
Bobola, MS
Blank, A
Berger, MS
Stevens, BA
Silber, JR
Citation: Ms. Bobola et al., Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas, CLIN CANC R, 7(11), 2001, pp. 3510-3518
Authors:
Rostomily, RC
Halligan, J
Geyer, R
Stelzer, K
Lindsley, K
Berger, MS
Citation: Rc. Rostomily et al., Permanent low-activity I-125 seed placement for the treatment of pediatricbrain tumors: Preliminary experience, PED NEUROS, 34(4), 2001, pp. 198-205
Authors:
Sievers, EL
Larson, RA
Stadtmauer, EA
Estey, E
Lowenberg, B
Dombret, H
Karanes, C
Theobald, M
Bennett, JM
Sherman, ML
Berger, MS
Eten, CB
Loken, MR
van Dongen, JJM
Bernstein, ID
Appelbaum, FR
Citation: El. Sievers et al., Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, J CL ONCOL, 19(13), 2001, pp. 3244-3254
Authors:
Berger, MS
Siyeon, K
Citation: Ms. Berger et K. Siyeon, Discrete flavor symmetries and mass matrix textures - art. no. 053006, PHYS REV D, 6405(5), 2001, pp. 3006
Authors:
Berger, MS
Siyeon, K
Citation: Ms. Berger et K. Siyeon, Anomaly-free flavor symmetry and neutrino anarchy - art. no. 057302, PHYS REV D, 6305(5), 2001, pp. 7302
Authors:
Barker, FG
Simmons, ML
Chang, SM
Prados, MD
Larson, DA
Sneed, PK
Wara, WM
Berger, MS
Chen, PC
Israel, MA
Aldape, KD
Citation: Fg. Barker et al., EGFR overexpression and radiation response in glioblastoma multiforme, INT J RAD O, 51(2), 2001, pp. 410-418
Authors:
Korth-Bradley, JM
Dowell, JA
King, SP
Liu, H
Berger, MS
Citation: Jm. Korth-bradley et al., Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin, PHARMACOTHE, 21(10), 2001, pp. 1175-1180
Authors:
Berger, MS
Citation: Ms. Berger, Intraoperative MR imaging: Making an impact on outcomes for patients with brain tumors, AM J NEUROR, 22(1), 2001, pp. 2-2
Authors:
Schiffbauer, H
Ferrari, P
Rowley, HA
Berger, MS
Roberts, TPL
Citation: H. Schiffbauer et al., Functional activity within brain tumors: A magnetic source imaging study, NEUROSURGER, 49(6), 2001, pp. 1313-1320
Authors:
Berger, MS
Citation: Ms. Berger, alpha v beta 3 and alpha v beta 5 integrin expression in glioma periphery - Comment, NEUROSURGER, 49(2), 2001, pp. 390-390
Authors:
Berger, MS
Citation: Ms. Berger, L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model - Comment, NEUROSURGER, 48(2), 2001, pp. 400-400
Authors:
Berger, MS
Citation: Ms. Berger, Genotype-phenotype correlation in gemistocytic astrocytomas - Comments, NEUROSURGER, 48(1), 2001, pp. 193-193
Authors:
Dowell, JA
Korth-Bradley, J
Liu, HJ
King, SP
Berger, MS
Citation: Ja. Dowell et al., Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in firstrelapse, J CLIN PHAR, 41(11), 2001, pp. 1206-1214
Authors:
Berger, MS
Citation: Ms. Berger, Higgs sector radiative corrections and s-channel production - art. no. 131801, PHYS REV L, 8713(13), 2001, pp. 1801
Authors:
Keles, GE
Lamborn, KR
Berger, MS
Citation: Ge. Keles et al., Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome, J NEUROSURG, 95(5), 2001, pp. 735-745
Authors:
Vates, GE
Berger, MS
Wilson, CB
Citation: Ge. Vates et al., Diagnosis and management of pituitary abscess: a review of twenty-four cases, J NEUROSURG, 95(2), 2001, pp. 233-241
Authors:
Szymanski, MD
Perry, DW
Gage, NM
Rowley, HA
Walker, J
Berger, MS
Roberts, TPL
Citation: Md. Szymanski et al., Magnetic source imaging of late evoked field responses to vowels: toward an assessment of hemispheric dominance for language, J NEUROSURG, 94(3), 2001, pp. 445-453
Authors:
Berger, MS
Citation: Ms. Berger, Two models of medieval Jewish marriage: A preliminary study (Varied conceptions of matrimony from a Near-Eastern and European cultural and historicalcontext), J JEWISH ST, 52(1), 2001, pp. 59-84
Authors:
Hirose, Y
Berger, MS
Pieper, RO
Citation: Y. Hirose et al., p53 effects both the duration of G(2)/M arrest and the fate of temozolomide-treated human glioblastoma cells, CANCER RES, 61(5), 2001, pp. 1957-1963
Authors:
Simmons, ML
Lamborn, KR
Takahashi, M
Chen, PC
Israel, MA
Berger, MS
Godfrey, T
Nigro, J
Prados, M
Chang, S
Barker, FG
Aldape, K
Citation: Ml. Simmons et al., Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients, CANCER RES, 61(3), 2001, pp. 1122-1128
Authors:
Sonoda, Y
Ozawa, T
Aldape, KD
Deen, DF
Berger, MS
Pieper, RO
Citation: Y. Sonoda et al., Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma, CANCER RES, 61(18), 2001, pp. 6674-6678
Authors:
Hirose, Y
Berger, MS
Pieper, RO
Citation: Y. Hirose et al., Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells, CANCER RES, 61(15), 2001, pp. 5843-5849